作者: David H Munn , Vincenzo Bronte
DOI: 10.1016/J.COI.2015.10.009
关键词:
摘要: Effective immunotherapy, whether by checkpoint blockade or adoptive cell therapy, is limited in most patients a key barrier: the immunosuppressive tumor microenvironment. Suppression of tumor-specific T cells orchestrated activity variety stromal myeloid and lymphoid cells. These often display inducible suppressive mechanisms that are triggered same anti-tumor inflammatory response immunotherapy intends to create. Therefore, more comprehensive understanding how milieu develops persists critical order harness full power cancer.